Highvista Strategies 13F annual report
Highvista Strategies is an investment fund managing more than $247 billion ran by Nicholas Boston. There are currently 136 companies in Mr. Boston’s portfolio. The largest investments include Insmed Inc and Merus N.V, together worth $15.4 billion.
$247 billion Assets Under Management (AUM)
As of 7th August 2024, Highvista Strategies’s top holding is 126,780 shares of Insmed Inc currently worth over $8.49 billion and making up 3.5% of the portfolio value.
Relative to the number of outstanding shares of Insmed Inc, Highvista Strategies owns more than approximately 0.1% of the company.
In addition, the fund holds 116,718 shares of Merus N.V worth $6.91 billion, whose value grew 23.0% in the past six months.
The third-largest holding is Salesforce Inc worth $5.45 billion and the next is Axsome Therapeutics Inc worth $5.01 billion, with 62,192 shares owned.
Currently, Highvista Strategies's portfolio is worth at least $247 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Highvista Strategies
The Highvista Strategies office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Nicholas Boston serves as the Chief Compliance Officer at Highvista Strategies.
Recent trades
In the most recent 13F filing, Highvista Strategies revealed that it had opened a new position in
Hashicorp Inc and bought 130,200 shares worth $4.39 billion.
The investment fund also strengthened its position in Salesforce Inc by buying
8,506 additional shares.
This makes their stake in Salesforce Inc total 21,185 shares worth $5.45 billion.
Salesforce Inc soared 18.5% in the past year.
On the other hand, there are companies that Highvista Strategies is getting rid of from its portfolio.
Highvista Strategies closed its position in SP Plus Corp on 14th August 2024.
It sold the previously owned 78,900 shares for $4.12 billion.
Nicholas Boston also disclosed a decreased stake in Merus N.V by approximately 0.1%.
This leaves the value of the investment at $6.91 billion and 116,718 shares.
One of the smallest hedge funds
The two most similar investment funds to Highvista Strategies are Prosight Management, L.P. and University Of Massachusetts Foundation. They manage $240 billion and $240 billion respectively.
Nicholas Boston investment strategy
Highvista Strategies’s portfolio is diversified across 12 sectors.
Currently, their heaviest sector is Health Care — making up 28.6% of
the total portfolio value.
The fund focuses on investments in the United States as
50.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
28% of the total holdings value.
On the other hand, small-cap stocks make up only 2.9% of the portfolio.
The average market cap of the portfolio companies is close to $80.2 billion.
The complete list of Highvista Strategies trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Insmed Inc |
No change
126,780
|
$8,494,260,000 | 3.53% |
| Merus N.V |
4.08%
116,718
|
$6,906,204,000 | 2.87% |
| Salesforce Inc |
67.09%
21,185
|
$5,446,664,000 | 2.27% |
| Axsome Therapeutics Inc |
28.16%
62,192
|
$5,006,456,000 | 2.08% |
| Hashicorp Inc |
Opened
130,200
|
$4,386,438,000 | 1.82% |
| Hess Corporation |
No change
28,900
|
$4,263,328,000 | 1.77% |
| Catalent Inc. |
Opened
75,600
|
$4,250,988,000 | 1.77% |
| Juniper Networks Inc |
No change
114,700
|
$4,181,962,000 | 1.74% |
| SP Plus Corp |
Closed
78,900
|
$4,120,158,000 | |
| Ansys Inc. |
No change
12,800
|
$4,115,200,000 | 1.71% |
| Microsoft Corporation |
25.29%
9,158
|
$4,093,168,000 | 1.70% |
| Equitrans Midstream Corporation |
Opened
310,000
|
$4,023,800,000 | 1.67% |
| Cerevel Therapeutics Hldng I |
No change
97,200
|
$3,974,508,000 | 1.65% |
| Albertsons Cos Inc |
No change
188,753
|
$3,727,872,000 | 1.55% |
| Amedisys Inc. |
No change
39,250
|
$3,603,150,000 | 1.50% |
| Amazon.com Inc. |
10.45%
17,993
|
$3,477,147,000 | 1.45% |
| Intuit Inc |
64.12%
4,863
|
$3,196,012,000 | 1.33% |
| Apogee Therapeutics Inc |
33.89%
78,942
|
$3,106,368,000 | 1.29% |
| Booking Holdings Inc |
No change
757
|
$2,998,856,000 | 1.25% |
| Maplebear Inc |
49.02%
92,988
|
$2,988,634,000 | 1.24% |
| Argenx Se |
2.09%
6,604
|
$2,839,984,000 | 1.18% |
| Xenon Pharmaceuticals Inc |
No change
72,715
|
$2,835,158,000 | 1.18% |
| Arcellx Inc |
29.34%
51,040
|
$2,816,898,000 | 1.17% |
| Xoma Corp Del |
No change
118,899
|
$2,816,717,000 | 1.17% |
| Indivior Plc |
No change
178,836
|
$2,803,226,000 | 1.17% |
| Enliven Therapeutics Inc |
5.57%
119,789
|
$2,799,469,000 | 1.16% |
| XPO Inc |
33.61%
25,480
|
$2,704,702,000 | 1.13% |
| Olema Pharmaceuticals, Inc. |
No change
247,880
|
$2,682,062,000 | 1.12% |
| Spyre Therapeutics Inc |
26.45%
113,550
|
$2,669,561,000 | 1.11% |
| Viridian Therapeutics Inc |
No change
198,484
|
$2,582,277,000 | 1.07% |
| Bicycle Therapeutics plc |
19.61%
127,255
|
$2,575,641,000 | 1.07% |
| Capri Holdings Limited |
No change
77,700
|
$2,570,316,000 | 1.07% |
| Vaxcyte, Inc. |
246.67%
32,313
|
$2,439,955,000 | 1.01% |
| Orthofix Med Inc |
Closed
167,900
|
$2,437,908,000 | |
| Cogent Biosciences, Inc. |
No change
281,093
|
$2,369,614,000 | 0.99% |
| Visa Inc |
No change
8,927
|
$2,343,070,000 | 0.97% |
| Fiserv, Inc. |
22.92%
15,553
|
$2,318,019,000 | 0.96% |
| Immunocore Hldgs Plc |
Closed
34,762
|
$2,259,530,000 | |
| Teva Pharmaceutical Inds Ltd |
Opened
136,500
|
$2,218,125,000 | 0.92% |
| Nuvalent Inc |
52.18%
28,698
|
$2,177,030,000 | 0.91% |
| Alphabet Inc |
7.30%
11,436
|
$2,097,591,000 | 0.87% |
| T-Mobile US, Inc. |
25.26%
11,900
|
$2,096,542,000 | 0.87% |
| Meta Platforms Inc |
8.91%
4,090
|
$2,062,260,000 | 0.86% |
| Legend Biotech Corp |
Closed
36,385
|
$2,040,835,000 | |
| Lithia Mtrs Inc |
Closed
6,401
|
$1,925,805,000 | |
| PTC Inc |
43.35%
10,581
|
$1,922,250,000 | 0.80% |
| SpringWorks Therapeutics, Inc. |
No change
50,987
|
$1,920,680,000 | 0.80% |
| Moonlake Immunotherapeutics |
29.31%
42,249
|
$1,857,689,000 | 0.77% |
| Seagate Technology Hldngs Pl |
39.06%
17,800
|
$1,838,206,000 | 0.76% |
| Autolus Therapeutics plc |
98.54%
518,820
|
$1,805,494,000 | 0.75% |
| Travere Therapeutics Inc |
No change
219,416
|
$1,803,600,000 | 0.75% |
| Equity Residential |
18.26%
25,900
|
$1,795,906,000 | 0.75% |
| Keros Therapeutics, Inc. |
No change
39,208
|
$1,791,806,000 | 0.75% |
| Western Digital Corp. |
19.19%
23,600
|
$1,788,172,000 | 0.74% |
| General Electric Co |
Closed
12,621
|
$1,768,076,000 | |
| RTX Corp |
42.24%
17,500
|
$1,756,825,000 | 0.73% |
| Corbus Pharmaceuticals Hldgs |
Opened
38,793
|
$1,755,383,000 | 0.73% |
| Dynavax Technologies Corp. |
No change
156,161
|
$1,753,688,000 | 0.73% |
| Kiniksa Pharmaceuticals International Plc. |
Closed
88,688
|
$1,749,814,000 | |
| MRC Global Inc |
25.39%
134,600
|
$1,737,686,000 | 0.72% |
| Adobe Inc |
Opened
3,100
|
$1,722,174,000 | 0.72% |
| Pfizer Inc. |
Opened
60,300
|
$1,687,194,000 | 0.70% |
| Laureate Education Inc |
31.44%
112,107
|
$1,674,879,000 | 0.70% |
| Intra-Cellular Therapies Inc |
No change
24,337
|
$1,666,841,000 | 0.69% |
| Kiniksa Pharmaceuticals Intl |
Opened
88,688
|
$1,655,805,000 | 0.69% |
| Verizon Communications Inc |
Closed
39,100
|
$1,640,636,000 | |
| HDFC Bank Ltd. |
23.71%
25,041
|
$1,610,888,000 | 0.67% |
| Crinetics Pharmaceuticals In |
121.63%
35,237
|
$1,578,265,000 | 0.66% |
| VanEck ETF Trust |
47.38%
46,200
|
$1,567,566,000 | 0.65% |
| Nu Hldgs Ltd |
20.51%
121,061
|
$1,560,476,000 | 0.65% |
| Revolution Medicines Inc |
179.81%
40,083
|
$1,555,621,000 | 0.65% |
| Wesco International, Inc. |
30.99%
9,797
|
$1,553,020,000 | 0.65% |
| Duolingo, Inc. |
48.00%
7,400
|
$1,544,158,000 | 0.64% |
| Walmart Inc |
24.31%
22,500
|
$1,523,475,000 | 0.63% |
| Icici Bank Limited |
22.85%
52,147
|
$1,502,355,000 | 0.62% |
| NVIDIA Corp |
Opened
12,000
|
$1,482,480,000 | 0.62% |
| Liquidia Corp |
Opened
121,754
|
$1,461,048,000 | 0.61% |
| Aercap Holdings Nv |
Opened
15,600
|
$1,453,920,000 | 0.60% |
| IDEAYA Biosciences, Inc. |
58.85%
40,856
|
$1,434,454,000 | 0.60% |
| Tidewater Inc. |
Closed
15,300
|
$1,407,600,000 | |
| Camden Ppty Tr |
Closed
14,100
|
$1,387,440,000 | |
| Sea Ltd |
3.01%
19,341
|
$1,381,334,000 | 0.57% |
| Structure Therapeutics Inc |
6.19%
35,128
|
$1,379,477,000 | 0.57% |
| Live Nation Entertainment In |
Opened
14,600
|
$1,368,604,000 | 0.57% |
| Arvinas Inc |
No change
51,122
|
$1,360,868,000 | 0.57% |
| Eli Lilly & Co |
Opened
1,500
|
$1,358,070,000 | 0.56% |
| Transdigm Group Incorporated |
Closed
1,100
|
$1,354,760,000 | |
| Roper Technologies Inc |
Opened
2,400
|
$1,352,784,000 | 0.56% |
| Roivant Sciences Ltd |
40.25%
126,741
|
$1,339,652,000 | 0.56% |
| FirstService Corp |
Opened
8,700
|
$1,325,619,000 | 0.55% |
| Bright Horizons Fam Sol In D |
28.26%
11,800
|
$1,298,944,000 | 0.54% |
| Hunt J B Trans Svcs Inc |
Opened
8,000
|
$1,280,000,000 | 0.53% |
| Ge Healthcare Technologies I |
Opened
16,100
|
$1,254,512,000 | 0.52% |
| Pennymac Finl Svcs Inc New |
19.47%
13,237
|
$1,252,220,000 | 0.52% |
| Toast, Inc. |
Opened
48,300
|
$1,244,691,000 | 0.52% |
| HubSpot Inc |
Opened
2,100
|
$1,238,559,000 | 0.52% |
| Transocean Ltd |
6.59%
229,725
|
$1,229,029,000 | 0.51% |
| Mastercard Incorporated |
Closed
2,547
|
$1,226,559,000 | |
| Crowdstrike Holdings Inc |
13.51%
3,200
|
$1,226,208,000 | 0.51% |
| Viatris Inc. |
Closed
102,600
|
$1,225,044,000 | |
| Netflix Inc. |
Opened
1,800
|
$1,214,784,000 | 0.51% |
| Banco Bradesco S.A. |
34.28%
537,100
|
$1,203,104,000 | 0.50% |
| RBC Bearings Inc. |
Opened
4,400
|
$1,187,032,000 | 0.49% |
| Constellation Brands, Inc. |
4.55%
4,600
|
$1,183,488,000 | 0.49% |
| Micron Technology Inc. |
33.58%
8,900
|
$1,170,617,000 | 0.49% |
| Philip Morris International Inc |
23.84%
11,500
|
$1,165,295,000 | 0.48% |
| Alibaba Group Hldg Ltd |
3.88%
16,057
|
$1,156,104,000 | 0.48% |
| StoneCo Ltd |
36.23%
95,130
|
$1,140,609,000 | 0.47% |
| Perspective Therapeutics Inc |
Opened
113,550
|
$1,132,094,000 | 0.47% |
| BridgeBio Pharma Inc |
21.20%
44,572
|
$1,129,009,000 | 0.47% |
| Take-two Interactive Softwar |
Closed
7,600
|
$1,128,524,000 | |
| Advanced Micro Devices Inc. |
2.99%
6,900
|
$1,119,249,000 | 0.47% |
| Thermo Fisher Scientific Inc. |
Closed
1,900
|
$1,104,299,000 | |
| First Ctzns Bancshares Inc N |
Closed
661
|
$1,080,735,000 | |
| Tourmaline Bio Inc |
57.20%
83,397
|
$1,072,485,000 | 0.45% |
| Palo Alto Networks Inc |
Closed
3,700
|
$1,051,281,000 | |
| Terns Pharmaceuticals Inc |
No change
148,200
|
$1,009,242,000 | 0.42% |
| Coinbase Global Inc |
Closed
3,761
|
$997,116,000 | |
| Janux Therapeutics Inc |
Opened
23,332
|
$977,377,000 | 0.41% |
| Immatics N.v |
Opened
77,821
|
$904,280,000 | 0.38% |
| Alpine Immune Sciences Inc |
Closed
22,783
|
$903,118,000 | |
| Repare Therapeutics Inc. |
Closed
165,173
|
$777,965,000 | |
| Geron Corp. |
25.16%
179,799
|
$762,348,000 | 0.32% |
| CRH Plc |
9.82%
10,100
|
$757,298,000 | 0.32% |
| Protagonist Therapeutics Inc |
No change
21,229
|
$735,585,000 | 0.31% |
| Immuneering Corp |
Closed
254,513
|
$735,543,000 | |
| Bilibili Inc |
46.67%
46,857
|
$723,472,000 | 0.30% |
| Madrigal Pharmaceuticals Inc |
No change
2,534
|
$709,925,000 | 0.30% |
| Krystal Biotech Inc |
Closed
3,923
|
$698,019,000 | |
| Mirum Pharmaceuticals Inc |
No change
20,208
|
$690,912,000 | 0.29% |
| Abivax Sa |
14.29%
49,509
|
$654,509,000 | 0.27% |
| H World Group Ltd |
26.61%
19,029
|
$634,046,000 | 0.26% |
| Alnylam Pharmaceuticals Inc |
Opened
2,602
|
$632,286,000 | 0.26% |
| Ascendis Pharma A/S |
No change
4,527
|
$617,392,000 | 0.26% |
| Rhythm Pharmaceuticals Inc. |
No change
14,362
|
$589,704,000 | 0.25% |
| Trip.com Group Ltd |
6.91%
11,756
|
$552,532,000 | 0.23% |
| Mersana Therapeutics Inc |
Closed
122,315
|
$547,971,000 | |
| Syndax Pharmaceuticals Inc |
Closed
21,519
|
$512,152,000 | |
| Pliant Therapeutics, Inc. |
Closed
34,039
|
$507,181,000 | |
| JD.com Inc |
69.29%
19,183
|
$495,689,000 | 0.21% |
| Verona Pharma Plc |
No change
32,449
|
$469,213,000 | 0.20% |
| United Therapeutics Corp |
Opened
1,409
|
$448,837,000 | 0.19% |
| Soleno Therapeutics Inc |
Closed
10,428
|
$446,318,000 | |
| Ocular Therapeutix Inc |
Opened
61,859
|
$423,116,000 | 0.18% |
| Acadia Pharmaceuticals Inc |
Opened
25,878
|
$420,518,000 | 0.17% |
| Li Auto Inc. |
Closed
13,066
|
$395,638,000 | |
| Natera Inc |
Opened
3,568
|
$386,379,000 | 0.16% |
| KalVista Pharmaceuticals Inc |
No change
31,873
|
$375,464,000 | 0.16% |
| Sarepta Therapeutics Inc |
Opened
2,364
|
$373,512,000 | 0.16% |
| Baidu Inc |
23.70%
4,186
|
$362,005,000 | 0.15% |
| Couchbase Inc |
Closed
13,756
|
$361,920,000 | |
| 2seventy Bio Inc |
No change
93,500
|
$359,975,000 | 0.15% |
| New Oriental Ed & Technology |
2.13%
4,600
|
$357,558,000 | 0.15% |
| Celldex Therapeutics Inc. |
Opened
9,627
|
$356,295,000 | 0.15% |
| Kura Oncology Inc |
Opened
16,764
|
$345,171,000 | 0.14% |
| PDD Holdings Inc |
64.47%
2,578
|
$342,745,000 | 0.14% |
| KE Holdings Inc. |
44.62%
23,707
|
$335,454,000 | 0.14% |
| Vera Therapeutics Inc |
Opened
9,162
|
$331,481,000 | 0.14% |
| 4d Molecular Therapeutics In |
No change
15,532
|
$326,017,000 | 0.14% |
| TAL Education Group |
11.54%
29,900
|
$319,033,000 | 0.13% |
| Pharvaris N V |
No change
16,750
|
$314,900,000 | 0.13% |
| Apellis Pharmaceuticals Inc |
4.13%
7,566
|
$290,232,000 | 0.12% |
| Tyra Biosciences Inc |
Opened
16,078
|
$257,087,000 | 0.11% |
| Cabaletta Bio Inc |
No change
22,208
|
$166,116,000 | 0.07% |
| No transactions found | |||
| Showing first 500 out of 164 holdings | |||
Hedge funds similar to Highvista Strategies
- Greencape Capital PTY Ltd
- Keystone Services
- Ewa
- Team Hewins
- Pl Capital Advisors
- Davis Investment Partners
- Prosight Management, L.P.
- University Of Massachusetts Foundation
- Js Capital Management
- Gold Investment Management
- Kfa Private Wealth
- Tabor Asset Management, L.P.
- Wt Wealth Management
- Highview Capital Management de/